HK Stock MarketDetailed Quotes

02410 TYK MEDICINES-B

Watchlist

45.000
+1.350+3.09%

Not Open Dec 12 16:08 CST

16.69BMarket Cap-35.60P/E (TTM)

TYK MEDICINES-B Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

Turnover

----

--44.24M

Operating income

44.24M

Cost of sales

----

---24.2M

Operating expenses

-24.2M

Gross profit

20.04M

Administrative expenses

---40.1M

-112.47%-21.66M

-76.83%-59.31M

-41.01%-34.22M

---10.19M

---33.54M

---24.27M

Research and development expenses

---137.76M

-17.68%-64.7M

-8.46%-249.25M

-28.39%-188.9M

---54.98M

---229.81M

---147.12M

Revaluation surplus

---47.46M

-25.50%-23.73M

-12.56%-77.79M

-15.24%-57.37M

---18.91M

---69.11M

---49.78M

-Changes in the fair value of other assets

---47.46M

-25.50%-23.73M

-12.56%-77.79M

-15.24%-57.37M

---18.91M

---69.11M

---49.78M

Special items of operating profit

--11.22M

55.46%4.67M

57.64%25.41M

77.88%20.88M

--3M

--16.12M

--11.74M

Operating profit

-214.1M

-30.02%-105.42M

-21.82%-360.94M

-37.07%-259.61M

-81.08M

-296.3M

-189.39M

Financing cost

---5.43M

-10.48%-2.36M

-43.40%-22.24M

53.47%-6.57M

---2.14M

---15.51M

---14.13M

Earning before tax

-219.53M

-29.52%-107.78M

-22.89%-383.17M

-30.79%-266.18M

-83.21M

-311.8M

-203.52M

After-tax profit from continuing operations

-219.53M

-29.52%-107.78M

-22.89%-383.17M

-30.79%-266.18M

-83.21M

-311.8M

-203.52M

Earning after tax

-219.53M

-29.52%-107.78M

-22.89%-383.17M

-30.79%-266.18M

-83.21M

-311.8M

-203.52M

Minority profit

---480K

-24.15%-257K

8.03%-744K

2.89%-537K

---207K

---809K

---553K

Profit attributable to shareholders

-219.05M

-29.53%-107.52M

-22.97%-382.43M

-30.88%-265.65M

-83.01M

-310.99M

-202.97M

Basic earnings per share

-0.68

-17.24%-0.34

-17.86%-1.32

-24.32%-0.92

-0.29

-1.12

-0.74

Diluted earnings per share

-0.68

-17.24%-0.34

-17.86%-1.32

-24.32%-0.92

-0.29

-1.12

-0.74

Currency Unit

CNY

Accounting Standards

HKAS

Audit Opinions

Unqualified Opinion

Auditor

Ernst & Young

	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022
Turnover	----	----	----	----	----	--44.24M	--44.24M
Operating income						44.24M	44.24M
Cost of sales	----	----	----	----	----	---24.2M	---24.2M
Operating expenses						-24.2M	-24.2M
Gross profit						20.04M	20.04M
Administrative expenses	---40.1M	-112.47%-21.66M	-76.83%-59.31M	-41.01%-34.22M	---10.19M	---33.54M	---24.27M
Research and development expenses	---137.76M	-17.68%-64.7M	-8.46%-249.25M	-28.39%-188.9M	---54.98M	---229.81M	---147.12M
Revaluation surplus	---47.46M	-25.50%-23.73M	-12.56%-77.79M	-15.24%-57.37M	---18.91M	---69.11M	---49.78M
-Changes in the fair value of other assets	---47.46M	-25.50%-23.73M	-12.56%-77.79M	-15.24%-57.37M	---18.91M	---69.11M	---49.78M
Special items of operating profit	--11.22M	55.46%4.67M	57.64%25.41M	77.88%20.88M	--3M	--16.12M	--11.74M
Operating profit	-214.1M	-30.02%-105.42M	-21.82%-360.94M	-37.07%-259.61M	-81.08M	-296.3M	-189.39M
Financing cost	---5.43M	-10.48%-2.36M	-43.40%-22.24M	53.47%-6.57M	---2.14M	---15.51M	---14.13M
Earning before tax	-219.53M	-29.52%-107.78M	-22.89%-383.17M	-30.79%-266.18M	-83.21M	-311.8M	-203.52M
After-tax profit from continuing operations	-219.53M	-29.52%-107.78M	-22.89%-383.17M	-30.79%-266.18M	-83.21M	-311.8M	-203.52M
Earning after tax	-219.53M	-29.52%-107.78M	-22.89%-383.17M	-30.79%-266.18M	-83.21M	-311.8M	-203.52M
Minority profit	---480K	-24.15%-257K	8.03%-744K	2.89%-537K	---207K	---809K	---553K
Profit attributable to shareholders	-219.05M	-29.53%-107.52M	-22.97%-382.43M	-30.88%-265.65M	-83.01M	-310.99M	-202.97M
Basic earnings per share	-0.68	-17.24%-0.34	-17.86%-1.32	-24.32%-0.92	-0.29	-1.12	-0.74
Diluted earnings per share	-0.68	-17.24%-0.34	-17.86%-1.32	-24.32%-0.92	-0.29	-1.12	-0.74
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS
Audit Opinions	--	--	Unqualified Opinion	--	--	Unqualified Opinion	--
Auditor	--	--	Ernst & Young	--	--	Ernst & Young	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Trending HK Stocks